Cancer cell reprogramming: a promising therapy converting malignancy to benignity

Cancer cell reprogramming: a promising therapy converting malignancy to benignity

Abstract In the past decade, remarkable progress has been made in reprogramming terminally differentiated somatic cells and cancer cells into induced pluripotent cells and cancer cells with benign phenotypes. Recent studies have explored various approaches to induce reprogramming from one cell type...

Full description

Bibliographic Details
Main Authors: Lanqi Gong, Qian Yan, Yu Zhang, Xiaona Fang, Beilei Liu, Xinyuan Guan
Format: Article
Language:English
Published: Wiley 2019-08-01
Series:Cancer Communications
Subjects:
Cancer cell reprogramming
Transcription factor
Small molecule
MicroRNA
Exosome
Malignancy
Online Access:http://link.springer.com/article/10.1186/s40880-019-0393-5

Internet

http://link.springer.com/article/10.1186/s40880-019-0393-5

Similar Items